CAS 1630808-89-7

Fórmula: C22H20FN3O4

InChI: InChI=1S/C22H20FN3O4/c23-16-5-6-17-18(13-16)30-19(24-17)14-1-3-15(4-2-14)20(27)25-9-11-26(12-10-25)21(28)22(29)7-8-22/h1-6,13,29H,7-12H2

Clave InChI: DSTWHRGOCUOKDE-UHFFFAOYSA-N

SMILES: C1CC1(C(=O)N2CCN(CC2)C(=O)C3=CC=C(C=C3)C4=NC5=C(O4)C=C(C=C5)F)O

FT113

CAS: 1630808-89-7

FT113

Fórmula: C₂₂H₂₀FN₃O₄

Pureza: 97%

Peso molecular: 409.41

Ref: 54-BUP05718

FT113

CAS: 1630808-89-7

Fórmula: C₂₂H₂₀FN₃O₄

Pureza: 97%

Forma y color: Solid

Peso molecular: 409.4103

Ref: IN-DA01V40P

FT113

CAS: 1630808-89-7

FT113 is a novel potent inhibitor of fatty acid synthase (fasn, IC50 : 213 nM),and exhibits anti-cancer activity

Fórmula: C₂₂H₂₀FN₃O₄

Pureza: 97.05%

Forma y color: Solid

Peso molecular: 409.4103

Ref: TM-T7947

(4-(4-(6-FLUOROBENZO[D]OXAZOL-2-YL)BENZOYL)PIPERAZIN-1-YL)(1-HYDROXYCYCLOPROPYL)METHANONE

CAS: 1630808-89-7

Pureza: 97%

Peso molecular: 409.4169922

Ref: 10-F840860

FT113

CAS: 1630808-89-7

FT113 is a modification of the amino acid phenylalanine. FT113 is proposed to be involved in the etiology of heart disease. The FT-IR spectroscopy has been used for the diagnosis and detection of syncopal episodes. FT113 has been shown to activate anthranilate, an intermediate in the synthesis of heme, which may lead to an interaction with fatty acids and other biochemical substances that are involved in cellular physiology. This modification is also thought to have a structural role in heart disease.

Fórmula: C₂₂H₂₀FN₃O₄

Pureza: Min. 95%

Peso molecular: 409.41 g/mol

Ref: 3D-FQC80889